Combining blood flow and tissue Doppler imaging with N-terminal pro-type B natriuretic peptide for risk stratification of clinically stable patients with systolic heart failure

European Journal of Echocardiography

Volumn 11, Issue 4, 2010, Pages 333-340

  Dini, Frank Lloyd ^a,b   Rosa, Gian Marco ^b   Fontanive, Paolo ^c   Santonato, Valeria ^a   Napoli, Anna Maria ^c   Ciuti, Manrico ^c   Di Bello, Vitantonio ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

Dilated cardiomyopathy; Echocardiography; Heart failure; Natriuretic peptides

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; ARTIFICIAL HEART PACEMAKER; BLOOD FLOW VELOCITY; BLOOD SAMPLING; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CLINICAL ASSESSMENT; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; MULTIVARIATE ANALYSIS; OUTPATIENT; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SCORING SYSTEM; SURVIVAL RATE; SYSTOLIC HEART FAILURE; TISSUE DOPPLER IMAGING;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART FAILURE, SYSTOLIC; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RISK ASSESSMENT;

EID: 77952001424     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1093/ejechocard/jep207     Document Type: Article

References (32)

1. Sohn DW, Chai IH, Lee DJ, Kim HC, Kim HS, Oh BH et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997;30:474-80.
2. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 2000;102:1788-94.
3. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997;30:1527-33.
4. Hillis GS, Møller JE, Pellikka P, Gersh BJ, Wright RS, Ommen SR et al. Noninvasive estimation of left ventricular filling pressure by E/e' is a powerful predictor of survival after acute myocardial infarction. J Am Coll Cardiol 2004;43:360-7.
5. Wang M, Yip GWK, Wang AYM, Zhang Y, Ho PY, Tse MK et al. Peak early diastolic annular velocity by tissue Doppler adds independent and incremental prognostic value. J Am Coll Cardiol 2003;41:820-6.
6. Acil T, Wichter T, Stypmann J, Janssen F, Paul M, Grude M et al. Prognostic value of tissue Doppler imaging in patients with chronic congestive heart failure. Int J Cardiol 2005;103:175-81.
7. Liang HY, Cauduro SA, Pellikka PA, Bailey KR, Grossardt BR, Yang EH et al. Comparison of usefulness of echocardiographic Doppler variables to left ventricular end-diastolic pressure in predicting future heart failure events. Am J Cardiol 2006;97:866-71.
8. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with or without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 1990;82:1724-9.
9. Benedict C, Johnstone DE, Weiner DH, Bourassa MG, Bittner V, Kay R et al. Relation of neurohormonal activation to clinical variables and degree of ventricular dysfunction: a report from the Registry of Studies of Left Ventricular Dysfunction. SOLVD Investigators. J Am Coll Cardiol 1994;23:1410-20.
10. Troughton RW, Prior DL, Pereira JJ, Martin M, Fogarty A, Morehead A et al. Plasma B-Type natriuretic peptide levels in systolic heart failure. Importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol 2004;43:416-22.
11. Yu CM, Sanderson JE, Shum IOL, Chan S, Yeung LYC, Hung YT et al. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern. Eur Heart J 1996;17:1694-702.
12. Mak GS, DeMaria A, Clopton P, Maisel AS. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: comparison with tissue Doppler imaging recordings. Am Heart J 2004;148:895-902.
13. Paulus WJ, Tschöpe C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007;28:2539-50.
14. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al., Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63.
15. Appleton CP, Hatle LK, Popp RL. Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol 1988;12:426-40.
16. Yu CM, Sanderson JE, Marwick TH, Oh JK. Tissue Doppler imaging. A new prognosticator for cardiovascular diseases. J Am Coll Cardiol 2007;49:1903-14.
17. Troughton RW, Frampton CM, Yandle TG. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000;355:1126-30.
18. Keogh AM, Baron DW, Hickie JB. Prognostic guides in patients with idiopathic or chronic dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol 1990;65:903-8.
19. Saxon LA, Stevenson WG, MiddleKauff HR, Fonarow G, Woo M, Moser D et al. Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated Cardiomyopathy. Am J Cardiol 1993;72:62-5.
20. Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is clinician's Rosetta stone. J Am Coll Cardiol 1997;30:8-18.
21. Dokainish H, Zoghbi WA, Lakkis NM, Ambriz E, Patel R, Quinones MA et al. Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. J Am Coll Cardiol 2004;45:1223-6.
22. Bruch C, Rothenburger M, Gotzmann M, Sindermann J, Scheld HH, Breithardt G et al. Risk stratification in chronic heart failure: independent and incremental prognostic value of echocardiography and brain natriuretic peptide and its N-terminal fragment. J Am Soc Echocardiogr 2006;19:522-8.
23. Steimle AE, Stevenson LW, Kelimsky-Fallick C, Fonarow GC, Hamilton MA, Moriguchi JD et al. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. Circulation 1997;96:1165-72.
24. Lucas C, Johnson W, Hamilton MA, Fonarow GC, Woo MA, Flavell CM et al. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J 2000;140:824-6.
25. Goldberg LR, Jessup MR. Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction. Circulation 2006;113:2851-60.
26. Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997;350:1349-53.
27. Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 1989;261:884-8.
28. Nagueh S, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009;10:165-93.
29. Yang L, Wu W, Wang J, Zhang X. Quantification of global left ventricular systolic dysfunction in patients with coronary artery disease by pulsed Doppler tissue imaging: the value of mitral annulus time intervals. Echocardiography 2007;24:360-5.
30. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002;40:976-82.
31. Luchner A, Hengstenberg C, Lowel H, Riegger GAJ, Schunkert H, Holmer S. Effect of compensated renal dysfunction on approved heart failure markers. Direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Hypertension 2005;46:118-23.
32. Bruch C, Fisher C, Sindermann J, Stypmann J, Breithardt G, Gradaus R. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic peptide in patients with heart failure with versus without chronic kidney disease. Am J Cardiol 2008;102:469-74.